OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.520
-0.150 (-8.98%)
At close: Aug 31, 2026, 4:00 PM EDT
1.510
-0.010 (-0.66%)
After-hours: Aug 31, 2026, 7:30 PM EDT
OKYO Pharma Employees
OKYO Pharma had 5 employees as of March 31, 2026. The number of employees increased by 1 or 25.00% compared to the previous year.
Employees
5
Change (1Y)
1
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,789,931
Market Cap
79.77M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 5 | 1 | 25.00% |
| Mar 31, 2025 | 4 | 1 | 33.33% |
| Mar 31, 2024 | 3 | -5 | -62.50% |
| Mar 31, 2023 | 8 | 1 | 14.29% |
| Mar 31, 2022 | 7 | 1 | 16.67% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Pelthos Therapeutics | 92 |
| Fortress Biotech | 78 |
| Acrivon Therapeutics | 76 |
| ImmuCell | 73 |
| MAIA Biotechnology | 13 |
| Atara Biotherapeutics | 10 |
| Alterity Therapeutics | 9 |
OKYO News
- 7 days ago - Okyo Pharma management to meet virtually with Piper Sandler - TheFly
- 4 weeks ago - Okyo Pharma CSO Raj Patil purchases 3,363 shares at $1.49 - TheFly
- 4 weeks ago - OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer - GlobeNewsWire
- 5 weeks ago - OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026 - GlobeNewsWire
- 5 weeks ago - Okyo Pharma director John Brancaccio acquires 5,000 shares at $1.38 - TheFly
- 5 weeks ago - OKYO Pharma Announces Purchase of Shares by Director - GlobeNewsWire
- 5 weeks ago - Okyo Pharma CEO Robert Dempsey purchases 15,000 shares at $1.54 - TheFly
- 5 weeks ago - OKYO Pharma Announces Purchase of Shares by Chief Executive Officer - GlobeNewsWire